Company Name, Ticker, Suppliers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
APRE's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Aprea Therapeutics Inc News
Aprea Therapeutics Inc's Revenue per Employee
Aprea Therapeutics Inc's Net Profit Margin
Aprea Therapeutics Inc Business Description
Aprea Therapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Aprea Therapeutics Inc Growth Rates
Aprea Therapeutics Inc Profitability
Aprea Therapeutics Inc Valuation
Aprea Therapeutics Inc Management Effectiveness
Aprea Therapeutics Inc Financial Strength
Aprea Therapeutics Inc Efficiency
Aprea Therapeutics Inc Dividend
Financials
Aprea Therapeutics Inc Business Segments
Aprea Therapeutics Inc Income Statement
Aprea Therapeutics Inc Balance Sheets
Aprea Therapeutics Inc Cash Flow Statement
Aprea Therapeutics Inc Geographic Information
Suppliers
Aprea Therapeutics Inc Suppliers Performance
APRE Suppliers Stock Performance
APRE Suppliers Growth Rates
APRE Suppliers Data
APRE Suppliers Efficiency
APRE Suppliers Management Effectiveness
APRE Suppliers Valuation
APRE Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Aprea Therapeutics Inc Market Share
Aprea Therapeutics Inc Competition Performance
Aprea Therapeutics Inc Competitors Results
APRE Competitors Stock Performance
APRE Competitors Growth Rates
APRE Workforce Efficiency at the Competitors
APRE Competitors Efficiency
APRE Competitors Management Effectiveness
APRE Competitors Valuation
Customers & Markets
Aprea Therapeutics Inc Customers Demand
APRE Customers Expenditure Growth Rates
APRE Customers Performance
APRE Customers Stock Performance
APRE Customers Growth Rates
APRE Workforce Efficiency at the Customers
APRE Customers Efficiency
APRE Customers Management Effectiveness
APRE Customers Valuation
APRE Customers by Companys' Segments
Charts & Quotes
Aprea Therapeutics Inc Comparison Charts
APRE OHLC Charts
APRE's Tehnical Upper Indicators
APRE's Tehnical Lower Indicators
APRE's Weekly Charts
APRE's Monthly Charts
Aprea Therapeutics Inc's Profile
Company Charts and Quotes
Aprea Therapeutics Inc News
Aprea Therapeutics Inc's Executive Officers
Aprea Therapeutics Inc's Income Statement
Aprea Therapeutics Inc's Balance Sheets
Aprea Therapeutics Inc's Cash Flow Statement
Aprea Therapeutics Inc's Profitability
Aprea Therapeutics Inc's Financials
APRE's Tangible Leverage Ratio
Aprea Therapeutics Inc's Suppliers
Aprea Therapeutics Inc's Competitors
Aprea Therapeutics Inc's Markets & Customers
Aprea Therapeutics Inc's Market Share
APRE's Suppliers Valuation
APRE's Competitors Valuation
APRE's Charts Comparison
Aprea Therapeutics Inc's Customers Expenditure Growth Rates
Economic Indicators
Capital Expenditures Growth by Industry
Dividend Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
U.S. International Trade
News
Economy News
Stock News
Technical Analysis
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Aprea Therapeutics Inc
(
APRE
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Aprea Therapeutics Inc 's Yearly Net Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Net Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Net Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
APRE Annual Net Cash Flow Growth
2023
2022
2021
2020
Y / Y Annual Net Cash Flow Change
-
-
-
-
-
Annual Net Cash Flow (in millions $)
$-7.13
$-24.33
$-35.94
$-41.68
$0.00
APRE Company Profile
>>
Back to APRE Fundamentals at a Glance
>>
Back to APRE Growth Comparisons
Annual Net Cash Flow Growth Comment
Aprea Therapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2023 Annual Net Cash Flow within Healthcare Sector
Y/Y Net Cash Flow Growth %
2023 Annual Net Cash Flow
Livanova Plc
-79.76 %
$ 62.254 millions
Bausch and Lomb Corp